7.14.23 | Policy House Labor-HHS Spending Bill Shows Flagrant Disregard for Science and Public Health
The U.S. House of Representatives Appropriations Committee released its fiscal year 2024 funding bill for the Departments of Labor-HHS. SWHR President and CEO Kathryn G. Schubert, MPP, CAE released a statement in response to the bill’s release.
5.16.23 | Policy SWHR Endorses “Momnibus 2.0”
SWHR is pleased to once again offer its endorsement of the Black Maternal Health Momnibus Act (or Momnibus Act).
5.15.23 | Research and Clinical Trials Reflecting on 30 Years of The Revitalization Act: A Conversation with SWHR’s Founder
During a special conversation, SWHR President and CEO Kathryn Schubert, MPP, CAE will sit down with SWHR Founder and Board Member Florence Haseltine, PhD, MD to discuss SWHR’s role in passing the NIH Revitalization Act of 1993 and the progress that has been made in women’s health research since that time.
5.3.23 | Policy SWHR Response to House’s Passage of the Limit, Save, Grow Act of 2023
On Wednesday, April 26, the U.S. House of Representatives passed the Limit, Save, Grow Act of 2023. These cuts could have serious implications for non-defense discretionary funding – and namely to health care and health research funding.
4.18.23 | Policy SWHR Statement on Ruling in Alliance for Hippocratic Medicine et al v FDA et al
SWHR issued a statement in anticipation of the Supreme Court ruling in response to the preliminary ruling of Judge Kacskmaryk of the U.S. District Court for the Northern District of Texas in the Alliance for Hippocratic Medicine et al v FDA et al case.
4.14.23 | Policy “Research Initiatives to Fortify the Health of Women in Populations with Health Disparities:” A Presentation by Dr. Webb Hooper
Monica Webb Hooper, PhD, Deputy Director of NIMHD addressed members of the SWHR Policy Advisory Council to discuss NIMHD’s research framework, work within women’s health, and how NIMHD is working to cultivate a diverse scientific workforce.
3.31.23 | Autoimmune Final Policy Brief of Four-Part Series Shines Light on Need for Diversity Within Autoimmune Clinical Trials
Recognizing the significant impact that diversity has on the nation's ability to improve autoimmune outcomes and advance health equity, SWHR developed the policy brief, “The Need for Diversity in Autoimmune Disease Research Trials.”
3.31.23 | Autoimmune Third Policy Brief Highlights Role of Federal Agencies in Supporting Women with Autoimmune Diseases and Conditions
The SWHR policy brief, “Federal Agencies’ Work in Autoimmune Diseases and Conditions,” demonstrates how federal agencies are contributing to improved health and health care for women across the lifespan and why investments in these programs and initiatives should continue to be prioritized.
3.31.23 | Autoimmune Federal Agencies’ Work in Autoimmune Diseases and Conditions
The U.S. government—through its programs and initiatives—has an important role to play in improving the lives of those living with […]
